Stocks
Mutual Funds
ETFs
Pro Tools
Terminal
WealthView
Pricing
Learn More
mutual funds
invesco india pharma and healthcare fund directgrowth
Invesco Mutual Fund

Invesco India Pharma And Healthcare Fund Direct-Growth

Equity: Sectoral-Pharma - Growth (Open ended)
Risk levelCategoryBenchmark
Copyright © 2026 sharpely. All rights reserved.
Factsheet
SEBI Riskometer: Very HighCategory: Equity: Sectoral-PharmaBenchmark: BSE Healthcare Total Return IndexCheck Portfolio Overlap →
NAV: —+0.00%
-
1 Week returns: -
Category rank: -
1 Month returns: -
Category rank: -
1 Year CAGR: -
Category rank: -
3 Years CAGR: -
Category rank: -
5 Years CAGR: -
Category rank: -
AUM
-
Expense Ratio
-
Inception
1788998.00
P/E
-
P/B
-
Max Drawdown
-
Return 1M
-
Return 1Y
-
Return 3Y
-
Return 5Y
-
Alpha
-
Sharpe
-

Key Talking Points

Important talking points about the scheme's performance, expense ratio and other factors — grouped by positive, negative, and neutral stance.
Positive
Not enough talking points with positive stance
Negative
Not enough talking points with negative stance
Neutral
Not enough performance data

Since this is a relatively new scheme (less than 3 years), we do not have sufficient data to conduct meaningful performance analysis

Scheme Overview

The scheme seeks to generate long term capital appreciation by investing predominantly in equity and equity related securities of the companies in Pharmaceuticals, Healthcare and allied sectors

Scheme Category Overview →

Plan Variants

Invesco India Pharma And Healthcare Fund Direct-IDCW
Plan
IDCW
Payout
Irregular

Fund Managers

Aditya Khemani
Since: 18 Aug 2026
View details
Education
Mr. Khemani has done B.Com (Hons) and PGDM from IIM, Lucknow.
Past Experience
Prior to joining Invesco Mutual Fund, He was associated with Motilal Oswal Mutual Fund, HSBC AMC, SBI Mutual Fund, ICICI Prudential AMC and Morgan Stanley Advantage Services.

Key Scheme Details

Inception
9 Sep 2026
Expense Ratio
-
AUM
-
Lock in
No lock in
Taxation
Equity
Min. Investment
₹1,000
Min. Addl Investment
-
Min. SIP Investment
₹100
Exit load
Exit load of 0.50%, if redeemed within 3 months.

AMC Overview

Invesco Mutual Fund background and AUM insights, category-wise distribution and historical AUM growth.

AUM Analysis

AUM distribution as on date:
Jul 31, 2026
Total AUM: ₹ 1,60,871 Cr
Equity
₹ 91,407 Cr
Debt
₹ 35,904 Cr
Hybrid
₹ 32,838 Cr
Commodities
₹ 723 Cr
Dec 31, 2021Jan 31, 2022Feb 28, 2022Mar 31, 2022Apr 30, 2022May 31, 2022Jun 30, 2022Jul 31, 2022Aug 31, 2022Sep 30, 2022Oct 31, 2022Nov 30, 2022Dec 31, 2022Jan 31, 2023Feb 28, 2023Mar 31, 2023Apr 30, 2023May 31, 2023Jun 30, 2023Jul 31, 2023Aug 31, 2023Sep 30, 2023Oct 31, 2023Nov 30, 2023Dec 31, 2023Jan 31, 2024Feb 29, 2024Mar 31, 2024Apr 30, 2024May 31, 2024Jun 30, 2024Jul 31, 2024Aug 31, 2024Sep 30, 2024Oct 31, 2024Nov 30, 2024Dec 31, 2024Jan 31, 2025Feb 28, 2025Mar 31, 2025Apr 30, 2025May 31, 2025Jun 30, 2025Jul 31, 2025Aug 31, 2025Sep 30, 2025Oct 31, 2025Nov 30, 2025Dec 31, 2025Jan 31, 2026Feb 28, 2026Mar 31, 2026Apr 30, 2026May 31, 2026Jun 30, 2026Jul 31, 2026
equity24,753 Cr24,577 Cr24,276 Cr25,653 Cr25,381 Cr24,848 Cr23,923 Cr26,273 Cr27,388 Cr26,937 Cr28,044 Cr28,583 Cr27,860 Cr27,359 Cr27,045 Cr27,214 Cr28,250 Cr29,606 Cr31,092 Cr32,369 Cr32,853 Cr33,489 Cr32,883 Cr35,958 Cr38,378 Cr39,752 Cr40,964 Cr41,356 Cr43,756 Cr44,944 Cr49,301 Cr52,048 Cr54,364 Cr56,685 Cr54,836 Cr56,707 Cr58,378 Cr54,948 Cr50,951 Cr55,432 Cr58,049 Cr61,571 Cr65,580 Cr66,207 Cr66,639 Cr68,925 Cr73,813 Cr76,198 Cr76,663 Cr74,403 Cr76,496 Cr69,054 Cr79,187 Cr81,800 Cr87,853 Cr91,407 Cr
hybrid2,090 Cr2,209 Cr2,165 Cr2,119 Cr2,230 Cr2,259 Cr2,240 Cr2,685 Cr2,747 Cr2,854 Cr2,956 Cr3,387 Cr3,599 Cr4,111 Cr4,307 Cr3,796 Cr4,631 Cr5,592 Cr6,313 Cr7,068 Cr8,148 Cr9,332 Cr9,829 Cr11,475 Cr13,138 Cr14,119 Cr15,891 Cr15,913 Cr16,620 Cr17,463 Cr17,958 Cr19,186 Cr19,014 Cr19,404 Cr20,379 Cr20,106 Cr21,128 Cr20,925 Cr21,549 Cr21,983 Cr22,411 Cr24,816 Cr26,498 Cr26,863 Cr27,884 Cr29,828 Cr30,053 Cr30,532 Cr30,433 Cr31,696 Cr31,680 Cr29,344 Cr30,495 Cr31,271 Cr31,722 Cr32,838 Cr
debt16,097 Cr17,275 Cr16,617 Cr15,187 Cr13,262 Cr13,040 Cr12,226 Cr13,098 Cr12,736 Cr13,069 Cr13,404 Cr16,789 Cr15,179 Cr14,257 Cr14,120 Cr13,181 Cr14,053 Cr16,956 Cr16,429 Cr16,954 Cr17,143 Cr15,767 Cr17,373 Cr17,907 Cr14,921 Cr17,961 Cr20,666 Cr18,331 Cr20,948 Cr22,814 Cr20,294 Cr23,812 Cr24,623 Cr27,751 Cr30,702 Cr32,695 Cr28,786 Cr31,125 Cr31,218 Cr26,877 Cr30,644 Cr33,125 Cr30,518 Cr33,358 Cr32,773 Cr29,341 Cr34,035 Cr37,674 Cr34,395 Cr34,082 Cr33,714 Cr28,148 Cr32,680 Cr30,545 Cr31,739 Cr35,904 Cr
commodities78 Cr77 Cr83 Cr91 Cr88 Cr87 Cr87 Cr88 Cr87 Cr86 Cr85 Cr89 Cr89 Cr92 Cr91 Cr98 Cr97 Cr98 Cr95 Cr96 Cr96 Cr92 Cr98 Cr98 Cr99 Cr98 Cr97 Cr105 Cr114 Cr115 Cr115 Cr114 Cr119 Cr125 Cr141 Cr144 Cr201 Cr222 Cr233 Cr257 Cr278 Cr277 Cr283 Cr299 Cr316 Cr384 Cr427 Cr470 Cr509 Cr765 Cr756 Cr705 Cr727 Cr767 Cr696 Cr723 Cr
Total43,018 Cr44,138 Cr43,141 Cr43,050 Cr40,961 Cr40,234 Cr38,477 Cr42,144 Cr42,959 Cr42,946 Cr44,489 Cr48,848 Cr46,727 Cr45,819 Cr45,563 Cr44,288 Cr47,030 Cr52,253 Cr53,928 Cr56,488 Cr58,240 Cr58,680 Cr60,184 Cr65,438 Cr66,536 Cr71,930 Cr77,619 Cr75,706 Cr81,438 Cr85,335 Cr87,668 Cr95,159 Cr98,121 Cr1,03,966 Cr1,06,057 Cr1,09,652 Cr1,08,494 Cr1,07,220 Cr1,03,951 Cr1,04,548 Cr1,11,382 Cr1,19,790 Cr1,22,879 Cr1,26,726 Cr1,27,612 Cr1,28,478 Cr1,38,328 Cr1,44,874 Cr1,42,000 Cr1,40,946 Cr1,42,647 Cr1,27,251 Cr1,43,089 Cr1,44,383 Cr1,52,010 Cr1,60,871 Cr

AMC Details

AMC
Invesco Mutual Fund
CEO
Saurabh Nanavati(Chief Executive Officer)
CIO
Taher Badshah(Chief Investment Officer)
IRO
Suresh Jakhotiya
Trustee
Invesco Trustee Private Limited
Address
B-1001, B Wing, 10th Floor, Marathon Futurex,, N. M. Joshi Marg, Lower Parel,, Mumbai, Maharashtra, Mumbai

Frequently Asked Questions

What is the current NAV of Invesco India Pharma And Healthcare Fund Direct-Growth?
The current NAV of Invesco India Pharma And Healthcare Fund Direct-Growth is - as of -. The NAV of a mutual fund reflects the per-unit market value of the fund's holdings and is updated at the end of every trading day.
What is the AUM of Invesco India Pharma And Healthcare Fund Direct-Growth?
The AUM (Assets Under Management) of Invesco India Pharma And Healthcare Fund Direct-Growth is -. AUM represents the total market value of assets the fund currently manages on behalf of its investors.
What is the expense ratio of Invesco India Pharma And Healthcare Fund Direct-Growth?
The expense ratio of Invesco India Pharma And Healthcare Fund Direct-Growth is -% per annum. This is the annual fee charged by the fund house to manage your investment. A lower expense ratio means more of your returns stay with you — which is one reason direct plans have a lower expense ratio than regular plans.
Who is the fund manager of Invesco India Pharma And Healthcare Fund Direct-Growth?
Invesco India Pharma And Healthcare Fund Direct-Growth is managed by Aditya Khemani. You can check the full list of fund managers in the "Fund Manager" section above.
What is the benchmark of Invesco India Pharma And Healthcare Fund Direct-Growth?
The benchmark of Invesco India Pharma And Healthcare Fund Direct-Growth is BSE Healthcare Total Return Index. This is the index against which the fund's performance is measured. Consistently beating the benchmark over long periods is a key indicator of a fund manager's skill.
When was Invesco India Pharma And Healthcare Fund Direct-Growth launched?
Invesco India Pharma And Healthcare Fund Direct-Growth was launched on 9 Sep 2026. The fund has been in existence for -1 years. A longer track record gives investors more data to evaluate how the fund has performed across different market cycles.
What is the minimum investment in Invesco India Pharma And Healthcare Fund Direct-Growth?
The minimum investment in Invesco India Pharma And Healthcare Fund Direct-Growth is ₹1,000 for a lump sum and ₹100 per month for a SIP (Systematic Investment Plan). SIPs allow you to invest a fixed amount regularly, making it easier to build wealth over time without needing a large upfront amount.
What is the exit load on Invesco India Pharma And Healthcare Fund Direct-Growth?
Invesco India Pharma And Healthcare Fund Direct-Growth has an exit load — Exit load of 0.50%, if redeemed within 3 months.. Exit load is charged to discourage early withdrawals and protect long-term investors in the fund.
What category does Invesco India Pharma And Healthcare Fund Direct-Growth belong to?
Invesco India Pharma And Healthcare Fund Direct-Growth belongs to the Equity: Sectoral-Pharma category. You can view other funds in this category.